tradingkey.logo
tradingkey.logo
Search

Vivos Therapeutics Inc

VVOS
Add to Watchlist
0.410USD
+0.004+1.03%
Close 07-31 16:00ETQuotes delayed by 15 min
3.81MMarket Cap
LossP/E TTM

Vivos Therapeutics Inc

0.410
+0.004+1.03%
View Detailed Chart
TradingKey Chart
Intraday
1m
30m
1h
D
W
M
D

Today

+1.03%

5 Days

+4.32%

1 Month

-9.77%

6 Months

-74.69%

Year to Date

-79.80%

1 Year

-90.53%

Key Figures
0.406Open
0.420High
186.06KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
2.00%Turnover Ratio
0.406Prev. Close
0.398Low
46.70KTurnover
LossP/E Static
-2.56P/B
0.00%Div Yield TTM
-138.29%ROA
7.95052wk High
1.18Volume Ratio
-11.14MNet Profit
9.29MShares
-2.1360EPS TTM
6.09Beta
-1528.79%ROE
0.54552wk Low
5.32%Amplitude
50.67%Gross Margin
3.81MMarket Cap
-1.82Reward/Risk
5.73%Risk Rate

Key Insights

Vivos Therapeutics Inc's fundamentals are relatively weak, and its growth potential is significant.Its valuation is considered fairly valued, ranking 113 out of 199 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 2.12.In the medium term, the stock price is expected to trend down.The company has shown very weak stock market performance over the past month, in line with its fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Vivos Therapeutics Inc's Score

Industry at a Glance

Industry Ranking
113 / 199
Overall Ranking
228 / 4281
Industry
Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

Very Low
Very High
Positive

Vivos Therapeutics Inc Highlights

StrengthsRisks
Vivos Therapeutics, Inc. is a medical technology company focused on developing and commercializing diagnostic and treatment methods that promote sleep wellness and health for patients suffering from breathing and sleep issues such as obstructive sleep apnea (OSA) and snoring in adults. The Company's Complete Airway Repositioning and/or Expansion (CARE) devices are the oral appliances cleared by the United States Food and Drug Administration (FDA) for adult patients diagnosed with all severity levels of OSA (including severe OSA) and moderate-to-severe OSA in children ages 6 to 17 within the FDA cleared usage for such devices. The Company's products and services include Vivos CARE oral appliance therapy, Vivos oral appliances and therapies outside of CARE system, Vivos AireO2, Adjunctive Treatment, Treatment Navigator, Vivos Billing Intelligence Service (BIS) and Vivos Airway Intelligence Service, and others. The Company has sleep testing centers and associated medical sleep practice.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 26.39% year-on-year.
Growing
The company is in a growing phase, with the latest annual income totaling USD 17.44M.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 17.44M.
Overvalued
The company’s latest PE is -0.19, at a high 3-year percentile range.
Institutional Selling
The latest institutional holdings are 1.10M shares, decreasing 6.15% quarter-over-quarter.
Lower Market Activity
The company has less investor interest, with a 20-day turnover ratio of -0.08.

Analyst Rating

Based on 3 analysts
Buy
Current Rating
2.117
Target Price
+411.40%
Upside Space

Vivos Therapeutics Inc News

More news coming soon, stay tuned...

Earnings Forecast

Analyst Rating

Based on 3 analysts
Buy
Current Rating
2.117
Target Price
+411.40%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

109
Total
7
Median
9
Average
Company name
Ratings
Analysts
Vivos Therapeutics Inc
VVOS
3
Medtronic PLC
MDT
33
Dexcom Inc
DXCM
31
Zimmer Biomet Holdings Inc
ZBH
31
Stryker Corp
SYK
30
Abbott Laboratories
ABT
29
1
2
3
...
22

Indicators

Indicators
Sell(1)
Neutral(5)
Buy(1)
Indicators
Value
Direction
MACD(12,26,9)
0.016
Neutral
RSI(14)
40.323
Neutral
STOCH(KDJ)(9,3,3)
59.380
Neutral
ATR(14)
0.029
Low Volatility
CCI(14)
-18.942
Neutral
Williams %R
39.398
Buy
TRIX(12,20)
-1.049
Sell
StochRSI(14)
68.600
Neutral
Moving Average
Sell(5)
Neutral(0)
Buy(1)
Indicators
Value
Direction
MA5
0.411
Sell
MA10
0.407
Buy
MA20
0.424
Sell
MA50
0.522
Sell
MA100
0.778
Sell
MA200
1.428
Sell

Financial Indicators

EPS

Relevant data have not been disclosed by the company yet.

Total revenue

Relevant data have not been disclosed by the company yet.

Vivos Therapeutics Inc Info

Vivos Therapeutics, Inc. is a medical technology company focused on developing and commercializing diagnostic and treatment methods that promote sleep wellness and health for patients suffering from breathing and sleep issues such as obstructive sleep apnea (OSA) and snoring in adults. The Company's Complete Airway Repositioning and/or Expansion (CARE) devices are the oral appliances cleared by the United States Food and Drug Administration (FDA) for adult patients diagnosed with all severity levels of OSA (including severe OSA) and moderate-to-severe OSA in children ages 6 to 17 within the FDA cleared usage for such devices. The Company's products and services include Vivos CARE oral appliance therapy, Vivos oral appliances and therapies outside of CARE system, Vivos AireO2, Adjunctive Treatment, Treatment Navigator, Vivos Billing Intelligence Service (BIS) and Vivos Airway Intelligence Service, and others. The Company has sleep testing centers and associated medical sleep practice.
Ticker SymbolVVOS
CompanyVivos Therapeutics Inc
CEOHuntsman (R. Kirk)
Websitehttps://vivos.com/

Shareholders

Shareholders
Shareholders
Proportion
V-CO Investors, L.L.C.
9.87%
Skaff (Michael C.)
9.79%
Luo (Dawei)
4.17%
Armistice Capital LLC
1.82%
Intracoastal Capital, L.L.C.
1.67%
Other
72.68%

FAQs

What is the current price of Vivos Therapeutics Inc (VVOS)?

The current price of Vivos Therapeutics Inc (VVOS) is 0.41.

What is the symbol of Vivos Therapeutics Inc?

The ticker symbol of Vivos Therapeutics Inc is VVOS.

What is the 52-week high of Vivos Therapeutics Inc?

The 52-week high of Vivos Therapeutics Inc is 7.95.

What is the 52-week low of Vivos Therapeutics Inc?

The 52-week low of Vivos Therapeutics Inc is 0.55.

What is the market capitalization of Vivos Therapeutics Inc?

The market capitalization of Vivos Therapeutics Inc is 3.81M.

Is Vivos Therapeutics Inc (VVOS) currently rated as Buy, Hold, or Sell?

According to analysts, Vivos Therapeutics Inc (VVOS) has an overall rating of Buy, with a price target of 2.12.

What is the Earnings Per Share (EPS TTM) of Vivos Therapeutics Inc (VVOS)?

The Earnings Per Share (EPS TTM) of Vivos Therapeutics Inc (VVOS) is -2.06.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.